Yes, a woman with hemophilia can give birth, and most pregnancies result in healthy outcomes for both mother and baby. The process requires more planning and monitoring than a typical pregnancy, but with proper management, about 72% of hemophilia carriers deliver vaginally, and newborns generally arrive at healthy weights with strong vitality scores. The key is understanding how hemophilia affects each stage of pregnancy, delivery, and the weeks that follow.
How Pregnancy Itself Changes Clotting
Pregnancy triggers a natural increase in several clotting factors, which works in favor of women with hemophilia A. Factor VIII levels rise two- to three-fold over the course of pregnancy, peaking just before delivery. For some women with mild hemophilia A, this rise can push their clotting factor activity into a near-normal range by the third trimester.
Factor IX, however, barely budges during pregnancy. Women with hemophilia B don’t get the same protective boost, which means their bleeding risk stays relatively constant throughout all three trimesters and requires closer management from start to finish.
After delivery, these temporarily elevated clotting factors drop back to baseline. That decline can happen within three days or take up to three weeks, and it’s one reason the postpartum period carries its own set of risks.
What Delivery Looks Like
There’s no single “right” delivery method for women with hemophilia. Both vaginal delivery and cesarean section are considered safe options, and clinical guidelines don’t firmly recommend one over the other. In one study of 64 pregnancies among hemophilia carriers, about 72% delivered vaginally and 28% had cesarean sections.
What experts do agree on is that instrumental delivery, meaning the use of vacuum extractors or forceps, should be avoided. These tools put significant pressure on the baby’s head and are the strongest known risk factor for intracranial hemorrhage (bleeding inside the skull) in newborns who may have inherited hemophilia. In a large U.S. registry of 547 newborns with hemophilia, 2.6% experienced delivery-related intracranial hemorrhage, a small but serious risk that instrumental delivery makes worse.
If vaginal delivery is the plan, spontaneous labor is preferred over induced labor. Some evidence suggests that induction may increase stress on the baby during delivery, and for infants who might be affected by hemophilia, a gentler delivery reduces the chance of bleeding complications.
Pain Relief and Epidural Access
Getting an epidural isn’t automatically off the table, but it depends on your clotting factor levels. The widely accepted minimum threshold is a factor VIII or factor IX activity level of at least 50%, measured close to the time of delivery. Below that level, the risk of bleeding around the spinal cord from the epidural needle is too high.
Because factor VIII rises naturally during pregnancy, many women with hemophilia A reach that 50% threshold by the third trimester without any treatment. Women with hemophilia B, whose factor IX doesn’t climb much during pregnancy, are less likely to qualify for an epidural without clotting factor replacement beforehand. Your medical team will check your levels in the weeks leading up to delivery so there’s a clear plan for pain management before labor begins.
Postpartum Bleeding Risk
The most significant risk for women with hemophilia isn’t usually during delivery itself. It’s the days and weeks after. Postpartum hemorrhage, prolonged or heavy bleeding from the birth canal, occurred in about 12.5% of hemophilia carriers in the Saudi cohort study, compared to roughly 1-5% in the general population.
The reason ties back to those clotting factor levels that rose during pregnancy. Once the baby and placenta are delivered, factor VIII and von Willebrand factor begin to fall, sometimes quickly. A woman who had near-normal clotting during delivery can find herself back at her baseline low levels within days. This delayed drop means bleeding can start or worsen well after leaving the delivery room, sometimes a week or two postpartum. Medical teams typically monitor clotting levels for several days after birth, and the median hospital stay in the study was four days.
How Hemophilia Severity Matters
Not all women with hemophilia face the same level of risk. The condition is classified by how much clotting factor activity your blood has. Severe hemophilia means less than 1% of normal activity, moderate falls between 1% and 5%, and mild ranges from above 5% to below 40%. Women with factor levels between 30% and 60% can still experience abnormal bleeding, particularly during a major event like childbirth, even if they’ve never had obvious problems before.
Women with mild hemophilia A often have the smoothest pregnancies because the natural rise in factor VIII can compensate for their baseline deficit. Those with moderate or severe hemophilia, or any severity of hemophilia B, typically need clotting factor replacement therapy during and after delivery. Studies show that replacement therapy leads to generally favorable outcomes for both mother and baby, with no significant difference in complication rates based on the specific type or dose used.
What It Means for the Baby
Whether the baby inherits hemophilia depends on genetics, and this is often known or suspected before birth through genetic testing. If the baby is a boy, there’s a 50% chance he’ll have hemophilia if the mother carries the gene. If the baby is a girl, she has a 50% chance of being a carrier herself.
When a baby might be affected, the delivery plan is adjusted to minimize trauma. That means avoiding vacuum and forceps, being cautious with scalp monitors, and testing the baby’s clotting levels from cord blood shortly after birth. In the study of 64 pregnancies, newborn outcomes were reassuring: the median birth weight was 3,100 grams (about 6.8 pounds), and only 7.8% of newborns needed intensive care admission. Apgar scores, which measure a newborn’s immediate health, averaged 8.2 at one minute and 9.1 at five minutes, both well within the normal range.
Planning Ahead Makes the Difference
The single most important factor in a safe pregnancy with hemophilia is planning. Ideally, women with hemophilia or known carrier status connect with a hematologist and a high-risk obstetric team before becoming pregnant or early in the first trimester. This allows time to establish baseline clotting factor levels, track how those levels change as pregnancy progresses, and build a delivery plan that accounts for pain management, delivery method, and postpartum monitoring.
Factor levels are typically checked at the start of pregnancy, during the third trimester, and close to delivery. If levels remain too low for safe delivery or epidural placement, clotting factor replacement can be given preventively. With this kind of coordinated care, most women with hemophilia have pregnancies and deliveries that end with a healthy baby and a manageable recovery.